A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
Okeoghene AkpoigbeComfort Anim-KorantengRuhina TasminAmanda SammutPublished in: The Journal of rheumatology (2024)
Dermatomyositis (DM) with myositis-specific autoantibodies (MSAs) such as anti-Mi-2 antibody confers a negative risk for malignancy. 1 A diagnosis of DM carries a 24% risk of developing a malignancy. 2 .